Published in Br J Cancer on September 01, 1982
Current issues in the design and interpretation of clinical trials. Br Med J (Clin Res Ed) (1985) 1.49
Conservative treatment of early breast cancer. Long-term results of 1232 cases treated with quadrantectomy, axillary dissection, and radiotherapy. Ann Surg (1990) 1.28
Meta-analyses in cancer clinical trials: principles and pitfalls. World J Surg (2006) 0.75
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer (1976) 22.55
A new design for randomized clinical trials. N Engl J Med (1979) 7.85
The randomization and stratification of patients to clinical trials. J Chronic Dis (1974) 7.11
Allocation of patients to treatment groups in a controlled clinical study. Br J Cancer (1978) 5.25
Allocation of patients to treatment in clinical trials. Biometrics (1979) 2.13
Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics (1975) 18.25
British Regional Heart Study: cardiovascular risk factors in middle-aged men in 24 towns. Br Med J (Clin Res Ed) (1981) 14.25
Statistical guidelines for contributors to medical journals. Br Med J (Clin Res Ed) (1983) 10.90
Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet (2000) 9.80
Statistical problems in the reporting of clinical trials. A survey of three medical journals. N Engl J Med (1987) 8.64
Repeated measures in clinical trials: analysis using mean summary statistics and its implications for design. Stat Med (1992) 7.33
British Regional Heart Study: geographic variations in cardiovascular mortality, and the role of water quality. Br Med J (1980) 5.56
Risk factors for ischaemic heart disease: the prospective phase of the British Regional Heart Study. J Epidemiol Community Health (1985) 5.53
Maternal vitamin D intake and mineral metabolism in mothers and their newborn infants. Br Med J (1980) 4.97
A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. The NIAID AIDS Clinical Trials Group. N Engl J Med (1992) 4.71
A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators. N Engl J Med (1998) 4.68
Randomized trials or observational tribulations? N Engl J Med (2000) 4.49
CD4+ lymphocytes are an incomplete surrogate marker for clinical progression in persons with asymptomatic HIV infection taking zidovudine. Ann Intern Med (1993) 4.43
Social class differences in ischaemic heart disease in British men. Lancet (1987) 4.09
Identifying men at high risk of heart attacks: strategy for use in general practice. Br Med J (Clin Res Ed) (1986) 3.76
Can meta-analyses be trusted? Lancet (1991) 3.43
Long-term survival of patients with breast cancer: a study of the curability of the disease. Br Med J (1979) 3.29
An epidemiological study of workers producing enzyme washing powders. Lancet (1970) 2.98
Effect of stage of disease and drug dose on zidovudine susceptibilities of isolates of human immunodeficiency virus. J Acquir Immune Defic Syndr (1990) 2.90
A comparison of immediate with deferred zidovudine therapy for asymptomatic HIV-infected adults with CD4 cell counts of 500 or more per cubic millimeter. AIDS Clinical Trials Group. N Engl J Med (1995) 2.66
A scoring system to identify men at high risk of a heart attack. Health Trends (1987) 2.58
Risk factors for stroke in middle aged British men. BMJ (1991) 2.44
Lead exposure and children's intellectual performance. Int J Epidemiol (1987) 2.30
Regression of area mortality rates on explanatory variables: what weighting is appropriate? J R Stat Soc Ser C Appl Stat (1981) 2.26
Giving up smoking and the risk of heart attacks. A report from The British Regional Heart Study. Lancet (1986) 2.19
5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial. Lancet (2005) 2.15
Allocation of patients to treatment in clinical trials. Biometrics (1979) 2.13
On the design and analysis of randomized clinical trials with multiple endpoints. Biometrics (1993) 2.13
Short-term effects of air pollution on daily mortality in Athens: a time-series analysis. Int J Epidemiol (1994) 2.03
Effects of alcohol and smoking on blood lead in middle-aged British men. Br Med J (Clin Res Ed) (1982) 2.03
Efficiency comparisons of rank and permutation tests based on summary statistics computed from repeated measures data. Stat Med (2001) 2.00
The combination of randomized and historical controls in clinical trials. J Chronic Dis (1976) 2.00
Issues in data monitoring and interim analysis of trials. Health Technol Assess (2005) 1.96
Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting. Randomised Intervention Treatment of Angina. Lancet (1998) 1.94
Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group. Am Rev Respir Dis (1992) 1.89
Properties of proportional-hazards score tests under misspecified regression models. Biometrics (1984) 1.84
Biochemical and haematological response to alcohol intake. Ann Clin Biochem (1985) 1.84
British blood cholesterol values and the American consensus. Br Med J (Clin Res Ed) (1985) 1.80
Blood pressure and hypertension in middle-aged British men. J Hypertens (1988) 1.80
Does plasma cholesterol concentration predict mortality from coronary heart disease in elderly people? 18 year follow up in Whitehall study. BMJ (1991) 1.79
Health service costs of coronary angioplasty and coronary artery bypass surgery: the Randomised Intervention Treatment of Angina (RITA) trial. Lancet (1994) 1.78
Do men benefit more than women from an interventional strategy in patients with unstable angina or non-ST-elevation myocardial infarction? The impact of gender in the RITA 3 trial. Eur Heart J (2004) 1.74
Nonparametric estimation of lifetime and disease onset distributions from incomplete observations. Biometrics (1982) 1.74
High density lipoprotein cholesterol is not a major risk factor for ischaemic heart disease in British men. Br Med J (Clin Res Ed) (1986) 1.73
Commuter travel and sickness absence of London office workers. Br J Prev Soc Med (1972) 1.72
Analysis of doubly-censored survival data, with application to AIDS. Biometrics (1989) 1.65
Blood lead concentration, blood pressure, and renal function. Br Med J (Clin Res Ed) (1984) 1.60
Stopping rules and estimation problems in clinical trials. Stat Med (1988) 1.58
Ethnic differences in certified sickness absence. Br J Ind Med (1982) 1.57
Surrogate markers in AIDS: where are we? Where are we going? Ann Intern Med (1992) 1.57
Use of the Wei-Lin-Weissfeld method for the analysis of a recurring and a terminating event. Stat Med (1997) 1.57
Interim analyses for randomized clinical trials: the group sequential approach. Biometrics (1982) 1.57
Differences in physical characteristics, perinatal histories, and social backgrounds between children with growth hormone deficiency and constitutional short stature. Arch Dis Child (1981) 1.56
Alcohol and ischaemic heart disease in middle aged British men. Br Med J (Clin Res Ed) (1987) 1.51
Current issues in the design and interpretation of clinical trials. Br Med J (Clin Res Ed) (1985) 1.49
[The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting of observational studies]. Internist (Berl) (2008) 1.47
Long term survival analysis: the curability of breast cancer. Stat Med (1983) 1.44
Effects of tap water lead, water hardness, alcohol, and cigarettes on blood lead concentrations. J Epidemiol Community Health (1983) 1.43
The duration of zidovudine benefit in persons with asymptomatic HIV infection. Prolonged evaluation of protocol 019 of the AIDS Clinical Trials Group. JAMA (1994) 1.41
Mortality of shift and day workers 1956-68. Br J Ind Med (1972) 1.38
Absenteeism of shift and day workers. A study of six types of shift system in 29 organizations. Br J Ind Med (1972) 1.34
Interim analyses in randomized clinical trials: ramifications and guidelines for practitioners. Biometrics (1987) 1.30
Impact of missing data due to drop-outs on estimators for rates of change in longitudinal studies: a simulation study. Stat Med (2001) 1.28
Headaches and migraine in colour retouchers. Br J Ind Med (1970) 1.28
The variability of serum cholesterol measurements: implications for screening and monitoring. J Clin Epidemiol (1990) 1.26
The agonising negative trend in monitoring of clinical trials. Lancet (1999) 1.25
Analyzing doubly censored data with covariates, with application to AIDS. Biometrics (1993) 1.22
Post-war trends in sickness absence and unemployment in Great Britain. Lancet (1969) 1.22
Multiple regression in geographical mortality studies, with allowance for spatially correlated errors. Biometrics (1983) 1.15
Time trends in serum cholesterol before cancer death. Epidemiology (1997) 1.15
[Contribution of lead in drinking water to blood-lead]. Lancet (1977) 1.15
Combination chemotherapy for metastatic breast carcinoma. Prospective comparison of multiple drug therapy with L-phenylalanine mustard. Cancer (1976) 1.14
Estimation of the timing of perinatal transmission of HIV. Biometrics (2001) 1.14
Size of cancer clinical trials and stopping rules. Br J Cancer (1978) 1.13
Factors influencing household water lead: a British national survey. Arch Environ Health (1980) 1.13
Domiciliary thrombolysis by general practitioners. BMJ (1992) 1.11
Assessing treatment-time interaction in clinical trials with time to event data: a meta-analysis of hypertension trials. Stat Med (1998) 1.10
Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes (RECORD): study design and protocol. Diabetologia (2005) 1.09
Linearly divergent treatment effects in clinical trials with repeated measures: efficient analysis using summary statistics. Stat Med (1997) 1.09
Rosiglitazone RECORD study: glucose control outcomes at 18 months. Diabet Med (2007) 1.08
Wheeze associated with prenatal tobacco smoke exposure: a prospective, longitudinal study. ALSPAC Study Team. Arch Dis Child (2000) 1.07
Assigned shares in compensation for radiation-related cancers. Risk Anal (1986) 1.07
Parental death from heart disease and the risk of heart attack. Eur Heart J (1988) 1.06
Size and power of two-sample tests of repeated measures data. Biometrics (1993) 1.05
Factorial trials in cardiology: pros and cons. Eur Heart J (1994) 1.03
Neonatal head circumference, neonatal weight, and risk of hayfever, asthma and eczema in a large cohort of adolescents from Sheffield, England. Clin Exp Allergy (2003) 1.02
The role of risk factors in heart attacks occurring in men with pre-existing ischaemic heart disease. Br Heart J (1988) 1.01
Risk factors for ischaemic heart disease in British men. Br Heart J (1987) 1.01
Variation in the incidence of diverticular disease within the city of Edinburgh. Gut (1977) 1.00
A stochastic model for censored-survival data in the presence of an auxiliary variable. Biometrics (1976) 0.99
Estimation and comparison of rates of change in longitudinal studies with informative drop-outs. Stat Med (1999) 0.99
Sample size requirements for prospective studies, with examples for coronary heart disease. J Clin Epidemiol (1989) 0.99
Design and current status of ACTION: A Coronary disease Trial Investigating Outcome with Nifedipine GITS. Gastro-Intestinal Therapeutic System. Eur Heart J (1998) 0.98
Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: evidence from the CHARM programme. Heart (2006) 0.94
The contribution of drinking water lead to maternal blood lead concentrations. Clin Chim Acta (1979) 0.94
Prognosis of patients with acute myocardial infarction admitted to a coronary care unit. II. Survival after hospital discharge. Br Heart J (1977) 0.93
Relationship between sickness absence and meteorological factors. Br J Prev Soc Med (1972) 0.91